References
- Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29:278–287.
- Kuentz M. Oral self-emulsifying drug delivery systems, from biopharmaceutical to technical formulation aspects. J. Drug Del Sci Tech. 2011;21:17–26.
- Müllertz A, Ogbonna A, Ren S, et al. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. J Pharmacy Pharmacol. 2010;62:1622–1636.
- Prajapati HN, Dalrymple DM, Serajuddin ATM. A comparative evaluation of mono-, di- and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development. Pharm Res. 2012;29:285–305.
- Thomas N, Müllertz A, Graf A, et al. Influence of lipid composition and drug load on the in vitro performance of self-nanoemulsifying drug delivery systems. J Pharm Sci. 2012;101:1721–1731.
- Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6:231–248.
- MacGregor KJ, Embleton JK, Lacy JE, et al. Infleunce of lipolysis on drug absorption from the gastro-intestinal tract. Adv Drug Del Rev. 1997;25:33–46.
- Dahan A, Hoffman A. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Control Release. 2008;129:1–10.
- Mohsin K. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion. AAPS PharmSciTech. 2012;13:637–646.
- Williams HD, Sassene P, Kleberg K, et al. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations. J Pharm Sci. 2012;101:3360–3380.
- Williams HD, Anby MU, Sassene P, et al. Toward the establishment of standardized in vitro tests for lipid-based formulations, Part 2: the effect of bile salt concentration and drug loading on the performance of Type I, II, IIIA, IIIB and IV formulations during in vitro digestion. Mol Pharm. 2012;9:3286–3300.
- Alskär LC, Porter CJH, Bergström CAS. Tools for early prediction of drug loading in lipid-based formulations. Mol Pharm. 2016;13:251–261.
- Chen X-Q, Gudmundsson OS, Hageman MJ. Application of lipid-based formulations in drug discovery. J Med Chem. 2012;55:7945–7956.
- Gibson L. Lipid-based excipients for oral drug delivery. In: Hauss DJ, editor. Oral lipid-based formulations: enhancing the bioavailability of poorly water-soluble drugs. New York: Informa Healthcare; 2007. p. 33–61.
- Hansen CH. Hansen solubility parameters: a user’s handbook. Boca Raton FL: CRC Press Inc.; 2007.
- Sacchetti M, Nejati E. Prediction of drug solubility in lipid mixtures from the individual ingredients. AAPS PharmSciTech. 2012;13:1103–1109.
- Cao Y, Marra M, Anderson BD. Predictive relationships for the effects of triglyceride ester concentration and water uptake on solubility and partitioning of small molecules into lipid vehicles. J Pharm Sci. 2004;93:2768–2779.
- Patel DP, Li P, Serajuddin ATM. Enhanced microemulsion formation in lipid-based drug delivery systems by combining mono-esters of medium-chain fatty acids with di- or tri-esters. J Excip Food Chem. 2012;3:29–43.
- Gullapalli RP. Soft gelatin capsules (softgels). J Pharm Sci. 2010;99:4107–4148.
- Land LM, Li P, Bummer PM. The influence of water content of triglyceride oils on the solubility of steroids. Pharm Res. 2005;22:784–788.
- Stella VJ. Chemical drug stability in lipids, modified lipids, and polyethylene oxide-containing formulations. Pharm Res. 2013;30:3018–3028.
- Savla R, Browne J, Plassat V, et al. Review and analysis of FDA approved drugs using lipid-based formulations. Drug Dev Ind Pharm. 2017;43:1743–1758.